Trinity Biotech Short Long Term Debt Total Over Time
| TRIB Stock | USD 1.12 0.01 0.88% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Trinity Biotech Performance and Trinity Biotech Correlation. Trinity |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (2.25) | Revenue Per Share 6.968 | Quarterly Revenue Growth 0.14 | Return On Assets (0.1) |
The market value of Trinity Biotech plc is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Biotech's value that differs from its market value or its book value, called intrinsic value, which is Trinity Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Biotech's market value can be influenced by many factors that don't directly affect Trinity Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Short Long Term Debt Total Analysis
Compare Trinity Biotech plc and related stocks such as Star Equity Holdings, Standard Biotools, and Genetron Holdings Short Long Term Debt Total Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAB | 25.9 M | 10.1 M | 195.5 M | 195.5 M | 195.5 M | 195.7 M | 195 M | 195.2 M | 172.1 M | 60 M | 95.4 M | 111.6 M | 102.7 M | 98.2 M | 104.4 M |
| BDSX | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 36 M | 27.8 M | 10 M | 31.9 M | 60.7 M | 34.7 M |
| NDRA | 950 K | 950 K | 950 K | 950 K | 950 K | 950 K | 950 K | 22.51 | 22.51 | 707.1 K | 685.5 K | 679 K | 546.6 K | 394.4 K | 452.9 K |
| SERA | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 8.7 M | 128 K | 2.3 M | 1.9 M | 3.6 M |
| FONR | 2 M | 2.6 M | 15.8 M | 11.4 M | 8.2 M | 4.5 M | 516.9 K | 344.4 K | 313.6 K | 35.8 M | 34.7 M | 38.2 M | 37 M | 41.7 M | 43.8 M |
| STIM | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 59.6 M | 30.4 M | 34.3 M | 38.3 M | 39.5 M | 39.7 M | 62.5 M | 44.7 M |
| XGN | 2.6 M | 2.6 M | 2.6 M | 8.9 M | 18.5 M | 25.9 M | 18.8 M | 18.8 M | 24.7 M | 26.1 M | 26.7 M | 27.5 M | 34.5 M | 23.7 M | 23.8 M |
| SHC | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.8 B | 1.8 B | 1.7 B | 2 B | 2.3 B | 1.7 B |
| ACRS | 142 K | 142 K | 142 K | 142 K | 142 K | 142 K | 142 K | 142 K | 30.5 M | 658 K | 11.3 M | 693 K | 684 K | 426 K | 404.7 K |
| CSTL | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 24.5 M | 25.1 M | 8.1 M | 8.1 M | 13.3 M | 15.3 M | 14 M |
| PRE | 899.5 K | 899.5 K | 899.5 K | 899.5 K | 899.5 K | 899.5 K | 899.5 K | 899.5 K | 899.5 K | 899.5 K | 1.7 M | 5.3 M | 6.6 M | 2.4 M | 3.7 M |
| MDXH | 29.8 K | 207.4 K | 1.4 M | 848 K | 848 K | 848 K | 538 K | 884 K | 526 K | 11 M | 15.9 M | 15.6 M | 39.8 M | 41.3 M | 43.3 M |
| NOTV | 5.8 M | 8.4 M | 7.4 M | 6 M | 4.8 M | 5.3 M | 4.6 M | 9.6 M | 16.6 M | 36.4 M | 174.2 M | 386.5 M | 417.6 M | 480.3 M | 504.3 M |
Trinity Biotech plc and related stocks such as Star Equity Holdings, Standard Biotools, and Genetron Holdings Short Long Term Debt Total description
My Equities
My Current Equities and Potential Positions
| Trinity Biotech plc | TRIB |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Ireland |
| Exchange | NASDAQ Exchange |
USD 1.12
Check out Trinity Biotech Performance and Trinity Biotech Correlation. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Trinity Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.